Lichens comprise a large group of diverse species known to produce many secondary metabolites like aliphatic acids, depsides, depsidones, depsones, dibenzofurans, anthraquinones, chromones, xanthones etc. Lichens have been used in traditional medicine for the treatment of wounds, skin problems, and upper respiratory and gastrointestinal symptoms [21]. Many investigations reported the antioxidant, antibacterial, antiviral, antipyretic, anti-inflammatory, and cytotoxic activity of lichen extracts [2]. In our study Platismatia glauca was used as the source of atranorin and caperatic acid. Salazinic acid and squamatic acid were derived from Parmelia sulcata and Cladonia uncialis, respectively, while physodic acid was isolated from Hypogymnia physodes. Lecanoric acid was obtained from Hypocenomyce scalaris. Extracts of these lichen species were shown to possess antioxidant, antimicrobial, genotoxic, cytotoxic, and pro-apoptotic (anticancer) effects in breast and colon carcinoma cell lines [7, 22,23,24]. Although several lichen extracts have been shown to inhibit colon carcinogenesis [8, 13, 14], the mechanisms of the anticancer activity of either extracts or single isolated compounds remain largely unknown. The aim of this study was thus to partly fill this gap.
In the first step, we evaluated the cytotoxic effects of the chemicals with the use of the MTT assay. All the compounds dose-dependently reduced the viability of both HCT116 and DLD-1 colon carcinoma cells with the exception of lecanoric acid in DLD-1 cells. Physodic acid showed enhanced cytotoxicity at significantly lower concentrations than other chemicals; however, atranorin and caperatic acid also induced strong cytotoxic effects at the highest concentration applied. Thus, the concentration of physodic acid used in further treatments was lower than that of other compounds. Our results are in agreement with published literature. Previous studies on physodic acid investigated the cytotoxic properties of this depsidone against different cancer cell lines. Strong cytotoxicity was observed towards breast cancer (T-47D, MCF-7, and MDA-MB-231), human colon carcinoma (LS174), and human melanoma (FemX and A375) cells [7, 9, 10]. Interestingly, physodic acid showed selective cytotoxicity towards breast cancer cells, in comparison to non-tumorigenic cells (MCF-10A) [7]. The results of our study do not confirm such selectivity, as HaCaT cells were as susceptible to viability reduction by physodic acid as colorectal carcinoma cell lines. Other lichen compounds tested in our experiments showed weaker cytotoxic activity than physodic acid in all the cell lines. Moreover, the rest of the compounds (except squamatic acid) led to a milder decrease in viability in HaCaT keratinocytes, suggesting a certain degree of selectivity towards cancer cells. The results of our study, as well as the data presented by other authors, demonstrate that physodic acid, next to usnic acid [25], is a compound with potent cytotoxic activity against cancer cell lines. Moreover, published data have proven its pro-apoptotic properties [9]. Physodic acid stimulated apoptosis due to a reduction in Bcl2 level and stimulation of Bax expression and caspase-3 activity in A375 melanoma cells [10]. The stimulation of apoptosis in DLD-1 cells and HaCaT cells was also observed in our study. The stronger cytotoxic effects of physodic acid may be at least in small part related to its ability to lead to the downregulation of BIRC5 expression which encodes the anti-apoptotic survivin. The exact mechanisms of the induction of apoptosis by physodic acid in colorectal cancer cells require further elucidation.
It is widely accepted that the initiation and progression of colorectal carcinogenesis is significantly associated with aberrations in Wnt signaling. The canonical Wnt pathway is responsible for the control of cell proliferation, migration, and cell death by regulating the transcriptional activity of β-catenin through blocking its cytosolic sequestration. In physiological states, β-catenin-mediated transcription is activated by the presence of Wnt ligands which act on cell membrane receptors and block the activity of cytosolic protein complex consisting of APC, GSK3β, Axin, and casein kinase which is responsible for the stimulation of β-catenin proteasomal degradation. After nuclear translocation, β-catenin interacts with TCF/LEF transcription factors and induces the expression of genes responsible for the regulation of cell cycle (CCND1, c-MYC), cell migration (MMP-7), and apoptosis (BIRC5) and of other regulators including Axin2. Around half of CRC patients bear inactivating mutations in the APC gene. Also mutations in CTNNB1 gene encoding β-catenin and other pathway-related genes contribute to Wnt pathway aberrant activation. The importance of Wnt dysregulation in colon carcinogenesis makes it a promising therapeutic target. Several synthetic chemicals like sulindac [26] or a group of quinazoline compounds [27] were able to exert anticancer effects in colon carcinoma cell lines via inhibition of Wnt signaling. There is also evidence that structurally diverse bioactive food components may have similar effects [28].
The action of lichen secondary metabolites may be mediated by the modulation of cell signaling pathways. In this regard, atranorin (100-200 µM) induced p38 and Bax and led to cell cycle arrest and apoptosis induction in colorectal carcinoma HT-29 cells [8]. Additionally, atranorin and lecanoric acid (25-50 µM) but not structurally similar squamatic acid were able to reduce AhR-mediated XRE-dependent CYP1A1 gene expression [12]. On the other hand, salazinic acid and squamatic acid did not significantly affect the phosphorylation of ERK1/2 or Akt in human cancer cells [6]. Since several lichen extracts were shown to inhibit colon carcinogenesis which is frequently associated with disruptions in Wnt signaling, we wanted to elucidate whether the studied lichen chemicals are able to modulate this pathway in colon carcinoma cell lines.
Of all the analyzed chemicals in our study, only caperatic acid and physodic acid showed β-catenin-dependent transcription inhibition comparable to the action of the known β-catenin/TCF4 antagonist—PKF118-310, which was identified as a β-catenin inhibitor over a decade ago [29]. Although PKF118-310 effectively blocked β-catenin-dependent transcription in all the tested cell lines what was reflected by the decrease in the level of Axin2 transcript and protein, DLD-1 cells were more resistant to the inhibitory effects of lichen chemicals. The genetic profile in these cell lines is different. Among many other alterations, DLD-1 cells bear the mutation in APC gene while HCT116 cells are characterized by a monoallelic CTNNB1 activating mutation. It will require further elucidation what factors determine the Wnt inhibitory response exerted by these chemicals. The activity of PKF118-310 and caperatic acid was highest after a 24 h incubation period and tended to decline with longer incubation time in contrast to physodic acid whose inhibitory effects appeared to be strongest after 48 h treatment. This indicates a possibility that caperatic acid and physodic acid may effectively modulate Wnt-driven carcinogenesis. On the other hand, both caperatic and physodic acid affected the function of Wnt signaling in HaCaT keratinocytes what suggests that interference with the activity of this pathway in normal cells may contribute to the appearance of side-effects, e.g., reduced tissue regeneration.
The mechanism of Wnt pathway inhibition (evidenced by the reduction in Axin2 expression, which is solely targeted by Wnt signaling) by caperatic acid and physodic acid does not seem to be dependent on the attenuation of the nuclear translocation of β-catenin since none of the compounds affected the level of expression or the subcellular localization of this protein. This suggests other mechanisms, possibly operating in the nucleus. Similarly, a diterpenoid henryin has been recently shown to interfere with β-catenin/TCF4 interaction in colorectal cancer cells [30]. In this regard, both caperatic and physodic acid mimicked to a large extent the action of PKF118-310, which reduces the transcriptional activity of β-catenin by blocking its interaction with TCF4. However, other mechanisms of transcription modulation, independent of modulating β-catenin, cannot be excluded. In fact, most naturally active compounds act pleiotropically thus it can be assumed that also other signaling pathways may undergo modulation by these compounds. This will require further study.
Importantly, caperatic acid led to an inhibition of migration of colorectal cancer cells and this effect was similar to the action of PKF118-310. Also, due to the down-regulation of MMP-7 expression by caperatic acid and physodic acid, we hypothesized that these compounds may affect cell invasion as a recent report has shown that the silencing of β-catenin in colorectal cancer cells blocked invasion by reducing MMP-7 and inducing E-cadherin [31]. Thus, we did not evaluate cell invasion in DLD-1 cell line which is known to lack the expression of MMP-7 [32]. Although the effect of caperatic acid on the expression of MMP-7 was higher than of physodic acid, both compounds showed a similar tendency to decrease the invasive potential of HCT116 cells suggesting the engagement of also other factors. Interestingly, PKF118-310 did not affect cell invasion but it might not be surprising since it did not alter the expression of MMP-7 after 48 h incubation. The ability of caperatic acid to diminish both the migratory and invasive potential of colon cancer cells is of utmost importance since cell spreading is associated with significantly worse prognosis in any cancer type. This, on the other hand, raises a possibility of using this compound or its derivatives for therapeutic purposes even in more advanced tumors. Indeed, adjuvant chemotherapy using 5-fluorouracil or oxaliplatin is used after surgery in the treatment of patients with nodal involvement. Probably, the therapeutic effects of caperatic acid would not be satisfactory based on the requirement of using high concentrations. In this regard, physodic acid shows more preferable pharmacodynamics. However, caperatic acid has an even greater potential to be used in colorectal cancer chemoprevention based on its reduced toxicity towards non-cancer cells. This is also based on the fact, that the dysregulation of Wnt pathway activity is detected as early as at the pre-malignant polyp stage. These hypotheses need verification in animal studies. Several other naturally occurring chemicals have been also identified as Wnt pathway inhibitors [28, 33]. Lupeol, silymarin, and grape compounds suppressed colon carcinogenesis through the inhibition of the nuclear translocation of β-catenin and attenuation of the transcriptional activity and expression of its target genes [34,35,36]. It has been recently proposed that lichen extracts could be applied as food additives making use of their preservative capacity [21]. Bioactive food components are especially beneficial since they often lack any pronounced toxicity. This is true for caperatic acid suggesting that it could be used in the chemoprevention of colorectal carcinogenesis based on its Wnt inhibitory activity.
Taken together, we have characterized the potential of caperatic acid and physodic acid to inhibit the expression of β-catenin-dependent genes and attenuate cell migration. We selected caperatic acid as the best inhibitor of Wnt signaling among the tested lichen compounds which has given its broadest effects on β-catenin-dependent gene expression and taking into account its cancer-specific cytotoxic effects. Further research should elucidate the detailed mechanisms of activity of these compounds and confirm the possible chemopreventive and chemotherapeutic use in other cancer cell and animal models.